Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is ...

Cardinal Health Inc.’s stock fell 4% early Monday, after the drug distributor and medical-laboratory products maker said its contracts with pharmacy-benefits manager OptumRx will expire at the ...

The company said the new DC will support its at-Home Solutions business and improve the delivery of medical supplies to ...

Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) yesterday and set a price ...

Cardinal Health prepares to enter direct patient care ... renamed Global Medical Products and Distribution; and the $1.2 billion unit manufacturing and delivering radioactive diagnostic drugs ...

Dublin, Ohio-based Cardinal Health, Inc. (CAH) is a manufacturer, distributor and provider of pharmaceuticals, medical & laboratory products, and performance & data solutions for healthcare ...

Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care ...

Cardinal Health (NYSE:CAH – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on ...

In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe ...